State Street Corp Cytom X Therapeutics, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 263,643 shares of CTMX stock, worth $279,461. This represents 0.0% of its overall portfolio holdings.

Number of Shares

263,643

Previous 263,643 -0.0%

Holding current value

$279,461

Previous $321,000 3.12%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.21 - $5.13 $4,637 - $19,663	-3,833 Reduced 1.43%	263,643 $321,000
Q1 2023 May 15, 2023	BUY	$1.48 - $2.88 $64,380 - $125,280	43,500 Added 19.42%	267,476 $403,000
Q2 2022 Aug 15, 2022	SELL	$1.53 - $2.89 $1.49 Million - $2.82 Million	-974,706 Reduced 81.31%	223,976 $410,000
Q1 2022 May 16, 2022	SELL	$2.67 - $4.68 $4.11 Million - $7.21 Million	-1,540,862 Reduced 56.25%	1,198,682 $3.2 Million
Q4 2021 Feb 14, 2022	SELL	$3.87 - $7.39 $5.02 Million - $9.59 Million	-1,297,393 Reduced 32.14%	2,739,544 $11.9 Million
Q3 2021 Nov 15, 2021	SELL	$4.32 - $6.43 $2.5 Million - $3.73 Million	-579,625 Reduced 12.56%	4,036,937 $20.5 Million
Q2 2021 Aug 16, 2021	BUY	$6.33 - $9.91 $7.96 Million - $12.5 Million	1,257,697 Added 37.44%	4,616,562 $29.2 Million
Q1 2021 May 17, 2021	BUY	$6.6 - $9.0 $8.63 Million - $11.8 Million	1,308,268 Added 63.8%	3,358,865 $26 Million
Q4 2020 Feb 16, 2021	SELL	$6.47 - $7.9 $638,310 - $779,390	-98,657 Reduced 4.59%	2,050,597 $13.4 Million
Q3 2020 Nov 10, 2020	SELL	$6.55 - $8.83 $303,887 - $409,667	-46,395 Reduced 2.11%	2,149,254 $14.3 Million
Q2 2020 Aug 14, 2020	BUY	$7.4 - $14.64 $8.94 Million - $17.7 Million	1,208,701 Added 122.47%	2,195,649 $18.3 Million
Q1 2020 May 11, 2020	BUY	$3.61 - $8.6 $3.56 Million - $8.49 Million	986,948 New	986,948 $7.57 Million

Others Institutions Holding CTMX

# of Institutions

Shares Held

50.7M

Call Options Held

112K

Put Options Held

8.3K

View Full List

About CytomX Therapeutics, Inc.

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $69.9M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

More about CTMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Cytom X Therapeutics, Inc. Transaction History